
Megtate 0.4mg Tablet MR
Marketer
Ridhima Biocare
Salt Composition
Tamsulosin (0.4mg)
Overview Megtate 0.4mg Tablet MR
Alfuzosin 0.4mg Modified-Release tablets are alpha-1 blockers indicated for benign prostatic hyperplasia (BPH) symptom management. This medication alleviates urinary difficulties, but doesn't shrink the prostate gland. Follow your doctor's prescribed dosage and regimen precisely. It can be taken with or without food, but consistently at the same time each day. Swallow the tablet whole; avoid crushing or chewing. Discontinue use only under medical supervision, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal results. Common side effects include lightheadedness, backache, chest discomfort, ejaculatory dysfunction, and retrograde ejaculation. Report any persistent or bothersome side effects promptly to your physician. Simple lifestyle adjustments can aid symptom control. Void when you first feel the urge, but avoid straining. Limit evening and pre-sleep consumption of caffeinated or alcoholic beverages. Before commencing treatment, disclose all current medications and health conditions to your doctor. Inform your ophthalmologist about alfuzosin use prior to cataract or glaucoma surgery. Patients with liver impairment should exercise caution and schedule regular check-ups as directed by their physician.
Primary Ingredients of Megtate 0.4mg Tablet MR
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Megtate 0.4mg Tablet MR
Managing benign prostatic enlargement
Major Benefits of Megtate 0.4mg Tablet MR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megtate 0.4mg Modified-Release Tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Megtate 0.4mg Tablet MR:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Megtate 0.4mg Tablet MR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megtate 0.4mg Modified-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.
How Megtate 0.4mg Tablet MR works:
Megtate 0.4mg Modified-Release tablets contain an alpha-adrenergic blocking agent. Its mechanism of action involves relaxing the bladder neck and prostate muscles, facilitating smoother urine flow. This improves bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Megtate 0.4mg Modified-Release tablets and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Data on Megtate 0.4mg Tablet MR use in pregnancy is lacking. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Megtate 0.4mg Tablet MR while breastfeeding is likely unsafe. Available data from humans indicates potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in women.
DrivingSAFE
Driving ability is typically unaffected by Megtate 0.4mg MR tablets.
KidneySAFE IF PRESCRIBED
Megtate 0.4mg modified-release tablets are considered safe for individuals with kidney impairment; dosage modification is not typically necessary. Nevertheless, data regarding its use in patients experiencing end-stage renal disease is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Megtate 0.4mg Tablet MR. Dosage modification of Megtate 0.4mg Tablet MR may be necessary; physician consultation is advised.
What if you forget to take Megtate 0.4mg Tablet MR :
Should you forget to take a Megtate 0.4mg MR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Megtate 0.4mg Tablet MR
| Label | Value |
|---|---|
| Chemical Category | Sulfonamide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
